Exosens SA EXENS

PRESS RELEASEMÉRIGNAC, FRANCE – 1 OCTOBER 2026 MONTHLY INFORMATION ON THE TOTAL NUMBER OF SHARESAND VOTING RIGHTS IN THE SHARE CAPITAL In accordance with articles L. 233-8 II of the French Commercial Codeand 223-16 of the General Regulations of the French Autorité des Marchés Financiers ISIN code: FR001400Q9V2 DateTotal number of sharesTotal number of voting rights30/09/202650,936,749Number of theoretical voting rights: 59,426,420 Number of exercisable voting rights*: 59,173,206* After deduction

When the U.S. Treasury 10 year yield pushes above the S&P 500 earnings yield for the first time in 25 years, investors are reminded that dependable power for AI data centers does not only mean computing chips. It also means reliable electricity. That is where long term, carbon free energy suppliers linked to the AI buildout can matter. This article walks through three stocks that sit squarely in that theme. The three companies below are just a first look. The full Nuclear Renaissance screen...

Geopolitical risk in Europe has moved from background noise to front page, with Danish intelligence now flagging the possibility of a limited Russian strike on a NATO state within months. That kind of warning can jolt capital out of some areas and into others very quickly. This article walks through three stocks exposed to this news, all drawn from our Western Defense and Security Stocks screener, and explores how investors might think about them now. The three stocks below are just a...

Exosens (ENXTPA:EXENS) lifted its full-year 2026 earnings guidance, with projected revenue now at €558 million to €570 million, reflecting stronger capacity ramp-up, firm demand in mission-critical imaging and nuclear instrumentation. Exosens shares have reacted to the guidance upgrade, with a 2.97% 1-day share price return and 10.68% 7-day share price return, while the 1-year total shareholder return of 41.70% points to firm momentum despite a modest 1.30% decline over the past month. Scan...

EXOSENS RAISES FULL-YEAR 2026 GUIDANCE, DRIVEN BY FASTER-THAN-EXPECTED CAPACITY RAMP-UP AND STRONG COMMERCIAL MOMENTUM Faster-than-expected ramp-up of additional European production capacity for high-performance image intensifier tubes, meeting growing global demand for advanced night vision solutions sooner than anticipatedAccelerating adoption of mission-critical imaging technologies across drone, counter-drone and long-range surveillance applicationsStrong momentum in nuclear instrumentation,

PHOTONIS DEFENSE AWARDED FIRST DELIVERY ORDER FOR U.S. ARMY’S BINOD PROGRAM, MARKING A KEY MILESTONE IN EXOSENS’ U.S. EXPANSION Photonis Defense, Exosens’ U.S. subsidiary, has been awarded a first delivery order for 1,600 complete systems under the U.S. Army’s Binocular Night Observation Device (BiNOD) program, with first deliveries expected by the end of 2026 and the bulk of deliveries scheduled throughout 2027The order represents the Low-Rate Initial Production (LRIP) phase of the BiNOD progra

EXOSENS ANNOUNCES THE PUBLICATION OF ITS 2026 HALF-YEARLY FINANCIAL REPORT Press release, Mérignac (France), 28 July 2026 – Exosens (EXENS; FR001400Q9V2), a high-tech company specializing in mission- and performance-critical amplification, detection and imaging technologies, announces that it has filed its 2026 half-yearly financial report for the six-month period ended 30 June 2026 with the Autorité des marchés financiers (AMF). The 2026 half-yearly financial report is available on the Company’

French defence company Exosens said on Tuesday it would triple thermal-camera production ‌capacity in 2026 to meet growing demand from drone and ‌counter-drone systems, as the night-vision equipment maker lifted expectations for results towards the upper ​end of its full-year guidance. Exosens said demand for its night-vision systems continued to benefit from higher defence spending and military modernisation programmes, while demand ​for advanced ​imaging systems for autonomous defence platforms ​accelerated, reinforcing its position in ‌a fast-growing defence market. "This expansion reinfo

EXOSENS TRIPLES THERMAL CAMERA PRODUCTION CAPACITY TO SUPPORT ACCELERATING DEMAND FOR DRONE AND COUNTER-DRONE APPLICATIONS Exosens plans to triple its thermal camera production capacity in 2026, reinforcing its industrial capabilities in the fastest growing defense marketsSupporting accelerating demand for compact thermal imaging solutions for seamless integration into next-generation drone and counter-drone systemsLeveraging Exosens’ UxV market expertise, agile supply chain and scalable industr

EXOSENS DELIVERS STRONG PERFORMANCE IN H1 2026, DRIVEN BY SUSTAINED MOMENTUM IN NIGHT VISION AND ACCELERATING DEMAND IN DEFENSE IMAGING 2026 OUTLOOK: NOW EXPECTING TO BE TOWARDS THE UPPER END OF THE GUIDANCE HIGHLIGHTS Sustained revenue growth of +15.3% to €253.1 million in H1 2026, including strong LFL growth of +11.4%, driven by accelerating demand for advanced defense imaging and night vision solutions Amplification revenue up +11.6%, with strong LFL1 growth (+10.0%), supported by growing dem

PRESS RELEASEMÉRIGNAC, FRANCE – 2 JULY 2026 HALF-YEARLY REPORT ON EXOSENS’ LIQUIDITY CONTRACT WITH KEPLER CHEUVREUX In accordance with the provisions of the French Financial Markets Authority’s decision n°2021-01 of 22 June 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice Under the liquidity contract entered into between Exosens (Ticker: EXENS; ISIN: FR001400Q9V2) and Kepler Cheuvreux, the following resources appeared on the liquidity account on 3

EXOSENS SECURES MAJOR LONG-TERM CONTRACT WITH BROLIS TO SUPPLY 17 000 HIGH-PERFORMANCE IMAGE INTENSIFIER TUBES FOR THE CZECH ARMED FORCES Exosens has secured a major contract with BROLIS to supply approximately 17,000 high-performance image intensifier tubes for the Czech Armed Forces through 2032This represents the largest procurement of image intensifier tubes ever undertaken by the Czech Republic, underscoring the field-proven operational performance, reliability, and quality of Exosens' adva

EXOSENS SECURES €140 MILLION IN EIB FINANCING TO FOSTER INNOVATION IN EUROPE’S DEFENSE AND SECURITY INDUSTRY EIB financing will support Exosens’ investments in advanced night vision and imaging technologies serving European defense, surveillance, and industrial end markets, which benefit from strong structural growth driversThis facility supports Exosens’ continued technology development and industrial footprint in Europe, in line with the EIB’s strategic priorities on innovation, strategic auto

EXOSENS’ COMBINED GENERAL MEETING OF 22 MAY 2026 Press release, Mérignac (France), 29 May 2026 – The Combined General Meeting (ordinary and extraordinary) of the shareholders of Exosens (the “Company”) was held on Friday, 22 May 2026, chaired by Mr. Jean-Hubert Vial, Chairman of the Board of Directors. The meeting was attended by Mr. Jérôme Cerisier, Chief Executive Officer, Ms. Quynh-Boï Demey, Chief Financial Officer, Ms. Bella Zisère, Human Resources Director, and the Company's Statutory Audi

EXOSENS DOUBLES PRODUCTION CAPACITY FOR COOLED INFRARED CAMERAS TO MEET ACCELERATING DEMAND IN LONG-RANGE COUNTER-DRONE SYSTEMS Exosens plans to double its production capacity for cooled infrared cameras in 2026, reinforcing its industrial platform in fast-growing defense and surveillance marketsThe expansion supports accelerating demand in long-range surveillance and counter-drone applications, where cooled infrared technology is a key enablerExosens’ ITAR-free digital imaging solutions are inc

As the European markets navigate a landscape of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable, with corporate earnings showing signs of positive momentum. In this environment, identifying stocks that might be trading below their fair value can be particularly appealing to investors seeking opportunities amidst broader economic uncertainties.

EXOSENS ANNOUNCES THE AVAILABILITY OF DOCUMENTS AND INFORMATION RELATING TO THE COMBINED GENERAL MEETING OF 22 MAY 2026 Press release, Mérignac (France), 30 April 2026 – Shareholders of Exosens (the ‘Company’) are invited to attend the Combined General Meeting (ordinary and extraordinary), which will be held on Friday, 22 May 2026 at 10:00 a.m. at: Apostrophe, 83 avenue Marceau, 75016 Paris, France. The meeting notice, including the agenda and the text of the proposed resolutions, was published

Exosens' sales jumped 19.7% in the first quarter, driven by booming demand for drones and anti-drone ‌systems, a trend the French defence technology group is betting on to ‌carry future growth. Exosens' products are in high demand as they can be deployed rapidly unlike large, capital-intensive systems, ​and the company has a strong offering and growing momentum in its tactical drones and drone-detection technologies, Bernstein analyst Aleksander Peterc said.

Exosens secured record orders for its advanced imaging solutions in unmanned defense platforms. The company signed a major deal with a European autonomous air defense developer for ultra compact thermal camera cores used in next generation interceptor drones. These contract wins highlight Exosens’ role as a digital imaging partner for defense customers across Europe, the U.S., and Asia. For investors tracking ENXTPA:EXENS, this order momentum comes as the share price stands at €63.65 and...